Zeng Chunyu, Yang Zhiwei, Wang Zheng, Jones John, Wang Xiaoyan, Altea Joanna, Mangrum Amy J, Hopfer Ulrich, Sibley David R, Eisner Gilbert M, Felder Robin A, Jose Pedro A
Department of Cardiology, Daping Hospital, Third Military Medical University, Chongqing, P.R. China.
Hypertension. 2005 Apr;45(4):804-10. doi: 10.1161/01.HYP.0000155212.33212.99. Epub 2005 Feb 7.
Angiotensin II type 1 (AT1) receptor and D1 and D3 dopamine receptors directly interact in renal proximal tubule (RPT) cells from normotensive Wistar-Kyoto rats (WKY). There is indirect evidence for a D5 and AT1 receptor interaction in WKY and spontaneously hypertensive rats (SHR). Therefore, we sought direct evidence of an interaction between AT1 and D5 receptors in RPT cells. D5 and AT1 receptors colocalized in WKY cells. Angiotensin II decreased D5 receptors in WKY cells in a time- and concentration-dependent manner (EC50=2.7x10(-9) M; t(1/2)=4.9 hours), effects that were blocked by an AT1 receptor antagonist (losartan). In SHR, angiotensin II (10(-8) M/24 hours) also decreased D5 receptors (0.96+/-0.08 versus 0.72+/-0.08; n=12) and to the same degree as in WKY cells (1.44+/-0.07 versus 0.92+/-0.08). However, basal D5 receptors were decreased in SHR RPT cells (SHR 0.96+/-0.08; WKY 1.44+/-0.07; n=12 per strain; P<0.05) and renal brush border membranes of SHR compared with WKY (SHR 0.54+/-0.16 versus WKY 1.46+/-0.10; n=5 per strain; P<0.05). Angiotensin II decreased AT1 receptor expression in WKY (1.00+/-0.04 versus 0.72+/-0.08; n=8; P<0.05) but increased it in SHR (0.96+/-0.04 versus 1.32+/-0.08; n=8; P<0.05). AT(1) and D5 receptors also interacted in vivo; renal D5 receptor protein was higher in mice lacking the AT1A receptor (AT1A-/-; 1.61+/-0.31; n=6) than in wild-type littermates used as controls (AT1A+/+; 0.81+/-0.08; n=6; P<0.05), and renal cortical AT1 receptor protein was higher in D5 receptor null mice than in wild-type littermates (1.18+/-0.08 versus 0.84+/-0.07; n=4; P<0.05). We conclude that D5 and AT1 receptors interact with each other. Altered interactions between AT1 and dopamine receptors may play a role in the pathogenesis of hypertension.
在正常血压的Wistar-Kyoto大鼠(WKY)的肾近端小管(RPT)细胞中,血管紧张素II 1型(AT1)受体与D1和D3多巴胺受体直接相互作用。有间接证据表明在WKY和自发性高血压大鼠(SHR)中存在D5与AT1受体相互作用。因此,我们寻求RPT细胞中AT1与D5受体相互作用的直接证据。D5和AT1受体在WKY细胞中共定位。血管紧张素II以时间和浓度依赖性方式降低WKY细胞中的D5受体(EC50 = 2.7×10(-9)M;t(1/2)= 4.9小时),这些效应被AT1受体拮抗剂(氯沙坦)阻断。在SHR中,血管紧张素II(10(-8)M / 24小时)也降低了D5受体(0.96±0.08对0.72±0.08;n = 12),且降低程度与WKY细胞相同(1.44±0.07对0.92±0.08)。然而,SHR的RPT细胞中基础D5受体减少(SHR 0.96±0.08;WKY 1.44±0.07;每个品系n = 12;P <0.05),与WKY相比,SHR的肾刷状缘膜中基础D5受体也减少(SHR 0.54±0.16对WKY 1.46±0.10;每个品系n = 5;P <0.05)。血管紧张素II降低WKY中AT1受体表达(1.00±0.04对0.72±0.08;n = 8;P <0.05),但增加SHR中AT1受体表达(0.96±0.04对1.32±0.08;n = 8;P <0.05)。AT1和D5受体在体内也相互作用;缺乏AT1A受体的小鼠(AT1A-/-;1.61±0.31;n = 6)肾D5受体蛋白高于用作对照的野生型同窝小鼠(AT1A+/+;0.81±0.08;n = 6;P <0.05),D5受体缺失小鼠的肾皮质AT1受体蛋白高于野生型同窝小鼠(1.18±0.08对0.84±0.07;n = 4;P <0.05)。我们得出结论,D5和AT1受体相互作用。AT1与多巴胺受体之间相互作用的改变可能在高血压发病机制中起作用。